All subjects · Biology · WBI12 (Unit 2)

Developing drugs: from digitalis to clinical trials

Drug testing has changed from trial and error on patients to carefully controlled trials. William Withering's work on foxglove marks an early step.

William Withering and digitalis

In the 18th century, William Withering investigated a folk herbal remedy (a 'soup' or tea of many herbs) used to treat dropsy, the swelling (oedema) often caused by heart failure. He identified foxglove (Digitalis purpurea) as the active ingredient.

He tried different doses on his patients: too little had no effect, too much was poisonous. In 1785 he published his results from 163 cases. His approach was trial and error on patients, without controls, which would not be accepted today.

Modern drug testing

Placebos and double-blind trials

Worked example

Explain why phase 3 trials use thousands of patients.

  1. Larger samples reduce the effect of chance.
  2. Rare side effects are more likely to be detected.
  3. Results are more reliable and can be generalised.

Answer: To make results reliable and to detect rarer side effects.

Key idea: Withering found foxglove (digitalis) treated dropsy using trial and error on patients. Today: pre-clinical, then phase 1 (healthy volunteers, safety), phase 2 (few patients, effect and dose), phase 3 (many patients, randomised double-blind vs placebo or existing drug).

Check yourself

  1. Which plant did William Withering identify as the active ingredient in a remedy for dropsy?
    • Willow
    • Garlic
    • Opium poppy
    • Foxglove
    Show answer

    Foxglove. Foxglove gives the drug digitalis.

  2. Who takes part in phase 1 trials?
    • Thousands of patients
    • A small number of healthy volunteers
    • Only animals
    • A small number of patients only
    Show answer

    A small number of healthy volunteers. Phase 1 tests safety in healthy people.

  3. What is the main purpose of phase 3 trials?
    • To test the drug on cells in a dish
    • To find whether it is safe in a few healthy people
    • To work out the chemical formula
    • To compare the drug with a placebo or existing treatment in a large number of patients
    Show answer

    To compare the drug with a placebo or existing treatment in a large number of patients. Phase 3 confirms effectiveness on a large scale.

  4. What does double-blind mean?
    • Neither patients nor doctors know who receives the drug
    • Patients are blindfolded
    • Two drugs are given at once
    • Only doctors know who gets the placebo
    Show answer

    Neither patients nor doctors know who receives the drug. This removes bias from both sides.

  5. Why is a placebo used?
    • To make the drug work faster
    • To reduce side effects
    • To see whether improvement is due to the drug or to patients' expectations
    • To treat a different disease
    Show answer

    To see whether improvement is due to the drug or to patients' expectations. It controls for the placebo effect.

  6. Why might a new drug be compared with an existing treatment instead of a placebo?
    • Withholding an effective treatment would be unethical
    • Placebos are too expensive
    • Placebos always work better
    • Existing drugs have no side effects
    Show answer

    Withholding an effective treatment would be unethical. Patients should not be denied effective treatment.

  7. What was a weakness of Withering's method by modern standards?
    • He used too many patients
    • He used animals only
    • There was no control group or placebo
    • He did not record his results
    Show answer

    There was no control group or placebo. Trial and error on patients without controls.

Practise with instant feedback

Sources

Last updated 7 November 2026. Spotted a mistake? Tell us.